( November 26, 2024, 11:54 AM EST) -- SAN JOSE, Calif. — Adamas Pharma LLC and Adamas Pharmaceuticals Inc. (collectively, Adamas) filed a citation of supplemental authority in the Ninth Circuit U.S. Court of Appeals one day after the court heard oral argument in a qui tam relator’s appeal of a district court’s ruling finding the public disclosure bar applicable and dismissing his claims that pharmaceutical companies violated the False Claims Act (FCA) by overcharging the federal government and states under Medicare and Medicaid....